Prostate cancer biology seems to be distinct among men of different ethnicities and races, as demonstrated by remarkable differences in the frequency ofERG oncogenic activation. In this Review, Sedarsky and colleagues discuss worldwide ERGalteration frequencies and consider how the data can be affected by variations in assay platforms and specimen types, as well as ethnic and geographical classifications, in order to realize the potential of precision medicine for men with prostate cancer.
- Jason Sedarsky
- Michael Degon
- Albert Dobi
